S3 Level Oral Clinical Practice Guideline and Its Development and Application in China

doi:10.13701/j.cnki.kqyxyj.2024.01.001

Abstract

Abstract: The emergence of newly international S3 level oral guideline provides the high quality recommendations for oral disease management. The adoption and adaptation of international guidelines should combine with the actual situation of our country. This article aims to introduce the classification system and basic methodology of the S3 level guidelines, and briefly introduce the current status of the adaptation and localization of the guideline in China.

Key words: clinical practice guideline, S3 level guideline, ADOLOPMENT, clinical practice

CHEN Zhi, HUANG Xinyue. S3 Level Oral Clinical Practice Guideline and Its Development and Application in China[J]. Journal of Oral Science Research, 2024, 40(1): 1-5.

References

[1] van der Weijden T, Boivin A, Burgers J, et al. Clinical practice guidelines and patient decision aids. An inevitable relationship [J]. J Clin Epidemiol, 2012, 65(6):584-589.
[2] Graham R, Mancher M, Miller Wolman D, et al. editors. Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust[M]. Washington (DC): National Academies Press (US), 2011.
[3] Qaseem A, Forland F, Macbeth F, et al. Guidelines international network: toward international standards for clinical practice guidelines [J]. Ann Intern Med, 2012, 156(7): 525-531.
[4] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发口腔相关病种诊疗指南(2022年版)的通知[Z]. 2022.
[5] Nothacker MJ, Muche-Borowski C, Kopp IB. Guidelines in the register of the association of scientific medical societies in germany-A quality improvement campaign [J]. Geburtshilfe Frauenheilkd, 2014, 74(3): 260-266.
[6] German Association of the Scientific Medical Societies, Commission SG. AWMF guidance manual and rules for guideline development [Z]. 2012.
[7] Hutchings A, Raine R. A systematic review of factors affecting the judgments produced by formal consensus development methods in health care [J]. J Health Serv Res Policy, 2006, 11(3): 172-179.
[8] Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes [J]. J Clin Epidemiol, 2011, 64(4): 395-400.
[9] Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias) [J]. J Clin Epidemiol, 2011, 64(4): 407-415.
[10] Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias [J]. J Clin Epidemiol, 2011, 64(12): 1277-1282.
[11] Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision [J]. J Clin Epidemiol, 2011, 64(12): 1283-1293.
[12] Mlika-Cabanne N, Harbour R, de Beer H, et al. Sharing hard labour: developing a standard template for data summaries in guideline development [J]. BMJ Qual Saf, 2011, 20(2): 141-145.
[13] Kirschneck C, Proff P, Lux C. Ideal treatment timing of orthodontic anomalies-a German clinical S3 practice guideline [J]. J Orofac Orthop, 2022, 83(4): 225-232.
[14] Sanz M, Herrera D, Kebschull M, et al. Treatment of stage Ⅰ-Ⅲ periodontitis-The EFP S3 level clinical practice guideline [J]. J Clin Periodontol, 2020, 47 Suppl 22(Suppl 22): 4-60.
[15] Rashid H, Lamberts A, Borradori L, et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology-Part Ⅰ [J]. J Eur Acad Dermatol Venereol, 2021, 35(9): 1750-1764.
[16] Schmidt E, Rashid H, Marzano AV, et al. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology-Part Ⅱ [J]. J Eur Acad Dermatol Venereol, 2021, 35(10): 1926-1948.
[17] Herrera D, Sanz M, Kebschull M, et al. Treatment of stage Ⅳ periodontitis: The EFP S3 level clinical practice guideline [J]. J Clin Periodontol, 2022, 49 Suppl 24: 4-71.
[18] Herrera D, Berglundh T, Schwarz F, et al. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline [J]. J Clin Periodontol, 2023, 50 Suppl 26: 4-76.
[19] Duncan HF, Kirkevang LL, Peters OA, et al. Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical practice guideline [J]. Int Endod J, 2023, 56 Suppl 3: 238-295.
[20] Schünemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT [J]. J Clin Epidemiol, 2017, 81: 101-110.
[21] 王子君,姚亮,刘练,等.GRADE指南改编方法“ADOLOPMENT”介绍[J].中国循证医学杂志,2018,18(1):109-115.
[22] West N, Chapple I, Claydon N, et al. BSP implementation of European S3-level evidence-based treatment guidelines for stage Ⅰ-Ⅲ periodontitis in UK clinical practice [J]. J Dent, 2021, 106: 103562.
[23] Sanz M, Herrera D, Kebschull M, et al. Adopción/Adaptación para España de la Guía de Práctica Clínica de Nivel S3 de la Federación Europea de Periodoncia (EFP)-Tratamiento de la Periodontitis en Estadios Ⅰ-Ⅲ [J]. International Journal of Interdisciplinary Dentistry, 2022, 15(SPC): 60-109.
[24] Kebschull M, Jepsen S, Kocher T, et al. Die Behandlung von Parodontitis Stadium Ⅰ bis Ⅲ [Z]. Die deutsche Implementierung der S3-Leitlinie "Treatment of Stage Ⅰ–Ⅲ Periodontitis " der European Federation of Periodontology (EFP) AWMF-Registernummer, 2020: 83-43.
[25] Fervers B, Burgers JS, Haugh MC, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure [J]. Int J Qual Health Care, 2006, 18(3): 167-176.
[26] 胡晶,陈茹,谢雁鸣,等.科学和规范的改编临床实践指南[J].中国循证儿科杂志,2012,7(3): 226-230.
[27] 傅亮,胡雁,卢洪洲,等.艾滋病相关症状管理指南改编的方法及效果评价[J].中华护理杂志,2015,50(9): 1037-1042.
[28] 王子君,周奇,邢丹,等.中国临床实践指南/共识解读类文献报告质量分析[J].协和医学杂志,2021,12(2): 260-267.
[29] 陈斌,李艳芬,陈日新,等.欧洲牙周病学会Ⅳ期牙周炎治疗S3级临床指南解读[J].中华口腔医学杂志,2022,57(12): 1195-1201.
[30] 邵金龙,于洋,吕春旭,等.欧洲牙周病学会牙周炎治疗S3级临床指南的介绍与应用解读[J].中华口腔医学杂志,2022,57(12): 1202-1208.
[31] 曹正国,高雅,曾宇.基于2018年牙周病国际新分类的重度牙周炎临床应用实践[J].口腔医学研究,2023,39(11): 943-951.